• 1
    Kidney Cancer. NCCN Clinical Practice Guideline in Oncology. National Comprehensive Cancer Network, Fort Washington, 2012.
  • 2
    Ljungberg B, Cowan NC, Hanbury DC et al. Guidelines on Renal Cell Carcinoma. European Association of Urology, Arnhem, The Netherlands, 2012.
  • 3
    Campbell SC, Novick AC, Belldegrun A et al. Guideline for management of the clinical T1 renal mass. J. Urol. 2009; 182: 12711279.
  • 4
    Patard JJ, Shvarts O, Lam JS et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J. Urol. 2004; 171: 21812185, quiz 2435.
  • 5
    Zini L, Perrotte P, Capitanio U et al. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer 2009; 115: 14651471.
  • 6
    Antonelli A, Ficarra V, Bertini R et al. Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi-institutional study. BJU Int. 2012; 109: 10131018.
  • 7
    Weight CJ, Larson BT, Gao T et al. Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival. Urology 2010; 76: 631637.
  • 8
    Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML. Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J. Urol. 2009; 182: 26012606.
  • 9
    Baillargeon-Gagne S, Jeldres C, Lughezzani G et al. A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma. BJU Int. 2010; 105: 359364.
  • 10
    Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach. BJU Int. 2012; 109: 14571462.
  • 11
    Du XL, Fang S, Coker AL et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer 2006; 106: 12761285.
  • 12
    D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat. Med. 1998; 17: 22652281.
  • 13
    Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007; 297: 278285.
  • 14
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012; 62: 1029.
  • 15
    Doeuk N, Guo DY, Haddad R et al. Renal cell carcinoma: stage, grade and histology migration over the last 15 years in a large Australian surgical series. BJU Int. 2011; 107: 13811385.
  • 16
    Nguyen MM, Gill IS, Ellison LM. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J. Urol. 2006; 176: 23972400; discussion 2400.
  • 17
    Weight CJ, Larson BT, Fergany AF et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J. Urol. 2010; 183: 13171323.
  • 18
    Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors – is there a difference in mortality and cardiovascular outcomes? J. Urol. 2009; 181: 5561; discussion 61–2.
  • 19
    Stephenson AJ, Hakimi AA, Snyder ME, Russo P. Complications of radical and partial nephrectomy in a large contemporary cohort. J. Urol. 2004; 171: 130134.
  • 20
    Abouassaly R, Alibhai SM, Tomlinson G, Timilshina N, Finelli A. Unintended consequences of laparoscopic surgery on partial nephrectomy for kidney cancer. J. Urol. 2010; 183: 467472.
  • 21
    Berndt SI, Carter HB, Schoenberg MP, Newschaffer CJ. Disparities in treatment and outcome for renal cell cancer among older black and white patients. J. Clin. Oncol. 2007; 25: 35893595.
  • 22
    Kates M, Whalen MJ, Badalato GM, McKiernan JM. The effect of race and gender on the surgical management of the small renal mass. Urol. Oncol. 2012; doi: 10.1016/j.urolonc.2012.05.005.
  • 23
    Porter MP, Lin DW. Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United States. Urol. Oncol. 2007; 25: 298302.
  • 24
    Cooperberg MR, Mallin K, Kane CJ, Carroll PR. Treatment trends for stage I renal cell carcinoma. J. Urol. 2011; 186: 394399.
  • 25
    Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 2006; 67: 254259.
  • 26
    Sun M, Trinh QD, Bianchi M et al. A non-cancer-related survival benefit is associated with partial nephrectomy. Eur. Urol. 2012; 61: 725731.
  • 27
    Thompson RH, Lane BR, Lohse CM et al. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 2012; 79: 356360.
  • 28
    Lane BR, Russo P, Uzzo RG et al. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J. Urol. 2011; 185: 421427.
  • 29
    Patard JJ, Pantuck AJ, Crepel M et al. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur. Urol. 2007; 52: 148154.
  • 30
    Crepel M, Jeldres C, Perrotte P et al. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment. Urology 2010; 75: 271275.